Sort   by:  
 Page size 
UnknownTargeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers.
Not available
S-EPMC6215820 | biostudies-literature
UnknownTargeting Potential of Innate Lymphoid Cells in Melanoma and Other Cancers.
Not available
S-EPMC10384206 | biostudies-literature
UnknownNatural Killer Cells and Type 1 Innate Lymphoid Cells in Hepatocellular Carcinoma: Current Knowledge and Future Perspectives.
Not available
S-EPMC8396475 | biostudies-literature
UnknownNKp30 isoforms and NKp46 transcripts in metastatic melanoma patients: Unique NKp30 pattern in rare melanoma patients with favorable evolution.
Not available
S-EPMC5214533 | biostudies-literature
UnknownType 2 Innate Lymphoid Cells Protect against Colorectal Cancer Progression and Predict Improved Patient Survival.
Not available
S-EPMC7867134 | biostudies-literature
UnknownRIPK3 controls MAIT cell accumulation during development but not during infection.
Not available
S-EPMC9922319 | biostudies-literature
UnknownImmunophenotyping of Stage III Melanoma Reveals Parameters Associated with Patient Prognosis.
Not available
S-EPMC6156792 | biostudies-literature
UnknownCD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment.
Not available
S-EPMC11962407 | biostudies-literature
UnknownAnticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.
Not available
S-EPMC4650573 | biostudies-literature
UnknownCaloric Restriction Mimetics Enhance Anticancer Immunosurveillance.
Not available
S-EPMC5715805 | biostudies-literature
Sort   by:  
 Page size